SCHEMBL19084770

SCHEMBL19084770

Cc1ccc2c(c1)c1cnccc1n2-c1ccccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
CYP17A1 P05093 2/20 0.41
CYP1A2 P05177 2/20 0.41
ALDH1A1 P00352 3/20 0.40
ELANE P08246 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAOA P21397 5/20 0.36
MAOB P27338 5/20 0.36
PTK2 Q05397 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680187 0.90 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAPOLBMAPT
SCHEMBL16625773 0.86 ACHE (0.42) ACHEGRIN1GRIN2ACYP1A2ALDH1A1
SCHEMBL12455274 0.85 ALDH1A1 (0.46) ACHEALDH1A1KDM4ELMNAPOLB
SCHEMBL4562149 0.82 ACHE (0.40) ACHEGRIN1GRIN2AALDH1A1ELANE
SCHEMBL1611065 0.81 ACHE (0.46) ACHEGRIN1GRIN2AALDH1A1ELANE
SCHEMBL4562476 0.81 ACHE (0.40) ACHEGRIN1GRIN2AALDH1A1ELANE
SCHEMBL17755594 0.79 ALDH1A1 (0.43) CYP1A2ALDH1A1KDM4ELMNAPOLB
SCHEMBL19862095 0.79 ALDH1A1 (0.40) ALDH1A1KDM4ELMNAPOLBMAPT
SCHEMBL261819 0.79 KMT2A (0.43) ACHECYP17A1CYP1A2ALDH1A1KDM4E
SCHEMBL16625774 0.78 ACHE (0.43) ACHEGRIN1GRIN2ACYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230122208-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-20 US disclosed
US-11548905-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-01-10 US disclosed
US-20170194562-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-07-06 US disclosed
US-20170194562-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230122208-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ZYX, SLC39A3, SOD3 ACHE 2249/4885GRIN1 2030/4885GRIN2A 2464/4885
US-11548905-B2 Organic electroluminescent materials and devices ZYX, SLC39A3, SOD3 ACHE 2249/4885GRIN1 2030/4885GRIN2A 2464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.